Electromechanical delay (emd) monitoring devices, systems and methods

Abstract

Implantable systems, and methods for use therewith, enable the monitoring of a patient's electromechanical delay (EMD) and arterial blood pressure. Paced cardiac events are caused by delivering sufficient pacing stimulation to cause capture. A cardiogenic impedance (CI) signal, indicative of cardiac contractile activity in response to the pacing stimulation being delivered, is obtained. One or more predetermined features of the CI signal are detected, and a value indicative of the patient's EMD is determined by determining a time between a delivered pacing stimulation and at least one of the detected one or more features of the CI signal. The value indicative of EMD can be used to more accurately determine metrics indicative of pulse arrival time (PAT), which can be used to estimate arterial blood pressure.

1 . For use with an implantable system, a method comprising:
 (a) causing paced cardiac events by delivering sufficient pacing stimulation to cause capture to the patient's heart;   (b) using one or more electrodes implanting within and/or on the patient's heart to obtain a cardiogenic impedance (CI) signal indicative of cardiac contractile activity while the patient's heart is being paced at step (a);   (c) detecting one or more predetermined features of the obtained CI signal; and   (d) determining one or more values indicative of the patient's electromechanical delay (EMD) by determining a time between a pacing stimulation delivered at step (a) and at least one of the one or more features of the CI signal detected at step (c);   (e) repeating steps (a), (b), (c) and (d) from time to time; and   (f) adjusting pacing performed at step (a) to reduce variance of at least one of the one or more values indicative of the patient's electromechanical delay (EMD).   
     
     
         2 . The method of  claim 1 , wherein the one or more predetermined features of the CI signal detected at step (c) is/are selected from the group consisting of:
 minimum amplitude of the CI signal;   maximum upward slope of the CI signal;   maximum amplitude of the CI signal; and   maximum downward slope of the CI signal.   
     
     
         3 . For use with an implantable system, a method comprising:
 (a) causing paced cardiac events by delivering sufficient pacing stimulation to cause capture to the patient's heart;   (b) using one or more electrodes implanting within and/or on the patient's heart to obtain a cardiogenic impedance (CI) signal indicative of cardiac contractile activity while the patient's heart is being paced at step (a);   (c) detecting one or more predetermined features of the obtained CI signal; and   (d) determining one or more values indicative of the patient's electromechanical delay (EMD) by determining a time between a pacing stimulation delivered at step (a) and at least one of the one or more features of the CI signal detected at step (c);   (e) repeating steps (a), (b), (c) and (d) from time to time; and   (f) monitoring changes in the patient's EMD based on changes in the value indicative EMD determined at step (d).   
     
     
         4 . The method of  claim 3 , further comprising:
 (g) monitoring the patient's HF condition based on changes in the patient's EMD.   
     
     
         5 . The method of  claim 3 , further comprising:
 (g) using an implanted sensor or implanted electrodes, remote from the patient's heart, to obtain a plethysmography signal indicative of changes in arterial blood volume remote from the patient's heart while the patient's heart is being paced at step (a);   (h) detecting one or more predetermined features of the plethysmography signal obtained at step (g);   (i) determining a metric indicative of pulse arrival time (PAT) by determining a time between a pacing stimulation delivered at step (a) and at least one of the one or more predetermined features of the plethysmography signal detected at step (h), minus the determined value indicative of EMD; and   (j) estimating the patient's arterial blood pressure based on the metric indicative of PAT determined at step (i).   
     
     
         6 . The method of  claim 5 , further comprising:
 (k) monitoring changes in the patient's EMD and arterial blood pressure based on changes in the value indicative EMD determined at step (d) and changes in the estimates of arterial blood pressure determined at step (j).   
     
     
         7 . The method of  claim 3 , wherein the one or more predetermined features of the CI signal detected at step (c) is/are selected from the group consisting of:
 minimum amplitude of the CI signal;   maximum upward slope of the CI signal;   maximum amplitude of the CI signal; and   maximum downward slope of the CI signal.   
     
     
         8 . An implantable system, comprising:
 a pulse generator configured to generate pacing stimulation sufficient to cause capture, which can be delivered to a patient's heart using at least one electrode implanted within or on the patient's heart;   a cardiogenic impedance measurement circuit configured to obtain a cardiogenic impedance (CI) signal indicative of cardiac contractile activity;   an electromechanical delay (EMD) monitor configured to:
 detect one or more predetermined features of a CI signal obtained using the CI measuring circuit while the patient's heart is being paced using the pulse generator; and 
 determine one or more values indicative of the patient's electromechanical delay (EMD) by determining a time between a pacing stimulation delivered to the patient's heart and at least one of the one or more predetermined features of the CI signal; and 
   a controller configured to adjust pacing to reduce variance of at least one of the one or more values indicative of EMD.   
     
     
         9 . The implantable system of  claim 8 , wherein the EMD monitor is also configured to monitor changes in the patient's EMD over time based on changes over time in at least one of the one or more values indicative of EMD. 
     
     
         10 . The implantable system of  claim 8 , further comprising:
 a heart failure (HF) monitor configured to monitor the patient's HF condition based on changes in the patient's EMD.   
     
     
         11 . The implantable system of  claim 8 , wherein the one or more predetermined features of the CI signal is/are selected from the group consisting of:
 minimum amplitude of the CI signal;   maximum upward slope of the CI signal;   maximum amplitude of the CI signal; and   maximum downward slope of the CI signal.